These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1384265)

  • 1. Putative mechanisms of action of tacrine in Alzheimer's disease.
    Adem A
    Acta Neurol Scand Suppl; 1992; 139():69-74. PubMed ID: 1384265
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.
    Wagstaff AJ; McTavish D
    Drugs Aging; 1994 Jun; 4(6):510-40. PubMed ID: 7521234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on synaptosomal uptake of neuromediators].
    Burov IuV; Baĭmanov TD; Maĭsov NI
    Biull Eksp Biol Med; 1992 Apr; 113(4):379-81. PubMed ID: 1356507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cholinergic perspectives in the treatment of Alzheimer's disease: tacrine].
    Royuela Rico A; Macías Fernández JA
    Rev Clin Esp; 1995 Jul; 195(7):473-8. PubMed ID: 7667523
    [No Abstract]   [Full Text] [Related]  

  • 5. Tacrine: a pharmacological review.
    Freeman SE; Dawson RM
    Prog Neurobiol; 1991; 36(4):257-77. PubMed ID: 1714613
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains.
    Nordberg A; Nilsson-Håkansson L; Adem A; Lai Z; Winblad B
    Prog Clin Biol Res; 1989; 317():1169-78. PubMed ID: 2557636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current.
    Drukarch B; Kits KS; Van der Meer EG; Lodder JC; Stoof JC
    Eur J Pharmacol; 1987 Sep; 141(1):153-7. PubMed ID: 2444444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§.
    Milelli A; De Simone A; Ticchi N; Chen HH; Betari N; Andrisano V; Tumiatti V
    Curr Med Chem; 2017; 24(32):3522-3546. PubMed ID: 28294041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy.
    Boller F; Orgogozo JM
    Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrine: first drug approved for Alzheimer's disease.
    Crismon ML
    Ann Pharmacother; 1994 Jun; 28(6):744-51. PubMed ID: 7919566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease.
    Drukarch B; Leysen JE; Stoof JC
    Life Sci; 1988; 42(9):1011-7. PubMed ID: 2893967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for Alzheimer's disease?
    Growdon JH
    N Engl J Med; 1992 Oct; 327(18):1306-8. PubMed ID: 1357552
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tacrine].
    Dávila C; Viteri C; de Castro P
    Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrine therapy for the dementia of Alzheimer's disease.
    Manning FC
    Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated administration of tacrine to normal rats: effects on cholinergic, glutamatergic, and GABAergic receptor subtypes in rat brain using receptor autoradiography.
    Sihver W; Günther P; Schliebs R; Bigl V
    Neurochem Int; 1997 Nov; 31(5):693-703. PubMed ID: 9364455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximizing function in Alzheimer's disease: what role for tacrine?
    Smucker WD
    Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiridin and tacrine modulation of the activity and plasticity of the cholinoreceptors of neurons of the common snail: phenomenology and mechanisms.
    Burov YuV ; Drozdova EI; Pivovarov AS; Robakidze TN
    Neurosci Behav Physiol; 1994; 24(6):507-12. PubMed ID: 7536306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease.
    Rossor M; Iversen LL
    Br Med Bull; 1986 Jan; 42(1):70-4. PubMed ID: 2869818
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
    Romero A; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tacrine in Alzheimer's disease].
    López de Munain A
    Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.